Wenger Vieli advises Arcoris Bio on CHF 6.3 million seed financing

"Wenger Vieli advised Swiss life sciences company Arcoris Bio on its CHF 6.3 million seed financing round co‑led by Ventura Ace and Zeiss Ventures, with participation from Zürcher Kantonalbank and private investors. Arcoris Bio, based in Schlieren, develops technologies to detect biomarkers in tissue samples."

Wenger Vieli advised Swiss life science and biotech company Arcoris Bio in connection with its seed financing round. The transaction comprised a CHF 6.3 million seed financing round co‑led by Ventura Ace and Zeiss Ventures, with additional participation from Zürcher Kantonalbank (ZKB) and new and existing private investors. Headquartered in Schlieren, Arcoris Bio develops technologies that facilitate the detection of biomarkers in tissue samples. Wenger Vieli represented client Arcoris Bio with a team composed by: Partner Beat Speck (corporate/M&A), senior associate Sabine Taxer (employment), associates Andrea Christen (notarial services), Dario Schönbächler (corporate/M&A) and Cyrill Barmettler (corporate/M&A), and junior lawyers Samuel Pils and Michelle Blattmann.

Wenger Vieli advises Arcoris Bio on CHF 6.3 million seed financing

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads